HRT 'reduces mortality risk in 50s'

HRT reduces mortality in women in their mid-50s, an analysis of data from 16,000 women has shown.

HRT: benefits greaterin mid 50's
HRT: benefits greaterin mid 50's

Dr Shelley Salpeter and colleagues at Santa Clara Medical Centre, California, examined 19 studies involving 16,283 women with a mean age of 55 years.

They found HRT was associated with a 27 per cent reduction in relative mortality risk and an absolute risk reduction of around 1 per cent.

The research, published in the American Journal of Medicine, sought to 'make sense of the accumulated evidence' on HRT. The researchers specifically wanted to address concerns raised by a 2002 study of data from the Women's Health Initiative (WHI).

The WHI study showed women aged over 63 years had an increased risk of developing a variety of conditions. This led to the assumption that HRT might increase health risks in all women and that these risks raised women's mortality risk.

Dr Salpeter believes the WHI results have been poorly inter-preted. She hoped the new study would help clarify the role of HRT in younger women.

The researchers stressed their findings needed to be interpreted in light of potential benefits and harms of hormone therapy.

'Available evidence indicates that hormone therapy in younger postmenopausal women increases the risk of breast cancer and pulmonary embolism, and reduces risk of cardiovascular events, colon cancer, and hip fracture,' they said.

'The total mortality benefit for younger women seen in the randomised trials and observa-tional studies indicates that the reduction in deaths from coronary heart disease, fracture, and colon cancer outweighed the increase in deaths from breast cancer, stroke, and pulmonary embolism,' the researchers added.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP training: Working remotely as a GP trainee during the pandemic

GP training: Working remotely as a GP trainee during the pandemic

Dr Zoe Brown was in her first year of GP training and pregnant as lockdown began....

GPs warn government off PCN-led test and trace system

GPs warn government off PCN-led test and trace system

GPs have rebuffed suggestions that primary care networks (PCNs) are ‘best placed’...

Map: Three-fold variation in GP practice list size between CCGs

Map: Three-fold variation in GP practice list size between CCGs

The list size of GP practices across England has grown rapidly over the past decade...

Advance decisions to refuse treatment - what GPs need to know

Advance decisions to refuse treatment - what GPs need to know

A recent case has underlined the need for GPs to communicate a patient’s known wishes...

Law changed to allow physios and paramedics to administer vaccines during pandemic

Law changed to allow physios and paramedics to administer vaccines during pandemic

A wider range of healthcare workers will be allowed to administer flu and potential...

Medicines shortages drive up GP workload as prescribing costs surge £158m

Medicines shortages drive up GP workload as prescribing costs surge £158m

Medicines shortages in England are continuing to drive up GP workload during the...